The 5-Cog Paradigm Improves Diagnosis, Management of Dementia
By Elana Gotkine HealthDay Reporter
TUESDAY, June 11, 2024 -- For older adults with cognitive concerns, the 5-Cog paradigm, a culturally adept, cognitive detection tool, paired with a clinical decision support, can improve diagnosis and management of dementia, according to a study published online June 4 in Nature Medicine.
Joe Verghese, M.B.B.S., from the Albert Einstein College of Medicine in New York City, and colleagues conducted a randomized controlled trial in primary care patients experiencing health disparities to examine whether the 5-Cog paradigm can reduce barriers to dementia diagnosis and care. Older adults with cognitive concerns were allocated to the 5-Cog paradigm or control in a 1:1 ratio (599 and 602, respectively).
The researchers found that compared with the control, the 5-Cog paradigm demonstrated threefold odds of improvement in dementia care actions, defined as any of the following end points within 90 days: new mild cognitive impairment syndrome or dementia diagnoses as well as investigations, medications, or specialist referrals ordered for cognitive indications (odds ratio, 3.43). There were no reports of serious intervention-related adverse events.
"The 5-Cog paradigm helped to improve dementia care actions related to diagnosis, investigations, and treatments that account for many implementation barriers and racial/ethnic differences in primary care patients presenting with cognitive concerns," the authors write. "This trial provides the evidence base to develop cognitive detection guidelines to promote practice change in primary care."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-06-12 01:15
Read more
- Over 50? How Long You Can Stand on One Leg Is Important
- One Dead, 10 Hospitalized in E. Coli Outbreak Linked to McDonald's Quarter Pounders
- Oct. 7 Tragedy Spurs Israeli Researcher to Study Grief Over Sibling Loss
- Anxiety/Depression Linked to HRQoL Losses in Seropositive RA
- IDSA: MVA-BN Vaccine Against Mpox Tolerated, Effective for Teens
- Election Stressing You Out? An Expert Has Coping Tips
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions